This Article was published on seekingalpha.com on October 5, 2012
Acadia Pharmaceuticals (ACAD) has been running up ahead of anticipated clinical trial results to be released next month. After a recent consolidation, ACAD may be ready to breakout for a second leg up in the coming weeks as we discuss herein.